Attachment 2

42096

Federal Register / Vol. 72, No. 147 / Wednesday, August 1, 2007 / Notices

jlentini on PROD1PC65 with NOTICES

transport passengers and cargo on U.S.
Government procured transportation for
both scheduled and charter flights,
subject to certain conditions.
Specifically, community airlines may
transport passengers and cargo on
scheduled and charter flights for which
a U.S. Government civilian department,
agency, or instrumentality:
(1) Obtains the transportation for itself
or in carrying out an arrangement under
which payment is made by the U.S.
Government or payment is made from
amounts provided for the use of the U.S.
Government, or
(2) Provides the transportation to or
for a foreign country or international or
other organization without
reimbursement, and the transportation
is:
(a) between any point in the United
States and any point in a Member State,
except—with respect to passengers
only—between points for which there is
a city-pair contract fare in effect, or
(b) between any two points outside
the United States.
This provision described above does
not apply to transportation funded by
the Secretary of Defense or the Secretary
of a military department.
The Federal Travel Regulation (FTR),
section 301–10.135 (b) (41 CFR 301–
10.135(b)) includes an exception to the
use of U.S. flag air carrier service when
the transportation is provided under a
bilateral or multilateral air
transportation agreement to which the
U.S. Government and the government of
a foreign country are parties, and which
the Department of Transportation has
determined meets the requirements of
the Fly America Act. As the U.S.–EU
Open Skies agreement is such an air
transportation agreement, the General
Services Administration (GSA) intends
to issue regulations addressing the
content of the provision on U.S.
Government procured transportation
included in the agreement to ensure that
all are aware of the change made by the
agreement. Regulations addressing air
passenger transportation will be
included in the FTR.
GSA is in the process of drafting a
proposed rule with request for
comments on proposed revisions to the
FTR that will be published in the
Federal Register.
Dated: July 17, 2007.
Becky Rhodes,
Deputy Associate Administrator.
[FR Doc. E7–14900 Filed 7–31–07; 8:45 am]
BILLING CODE 6820–14–P

VerDate Aug<31>2005

20:12 Jul 31, 2007

Jkt 211001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-07–0026]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Report of Verified Case of
Tuberculosis (RVCT), (OMB No. 0920–
0026)—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In the United States, an estimated 10
to 15 million people are infected with
Mycobacterium tuberculosis and about
10% of these persons will develop
tuberculosis (TB) disease at some point
in their lives. The purpose of this
project is to conduct the first major
revision since 1993 of the national
tuberculosis surveillance form, the
Report of Verified Case of Tuberculosis
(RVCT), to capture changes in the
diagnosis and treatment of TB, and to
better monitor trends in TB

PO 00000

Frm 00055

Fmt 4703

Sfmt 4703

epidemiology and outbreaks, in order to
develop strategies to meet the national
goal of TB elimination.
CDC currently conducts and
maintains the national surveillance
system pursuant to the provisions of
section 301(a) of the Public Service Act
[42 U.S.C. 241] and section 306 of the
Public Service Act [42 U.S.C. 241(a)].
Data are collected by 60 reporting areas
(the 50 states, the District of Columbia,
New York City, Puerto Rico, and 7
jurisdictions in the Pacific and
Caribbean). In 2001, CDC’s Division of
Tuberculosis Elimination (DTBE)
initiated a comprehensive review of the
RVCT. A work group with nearly 30
members from 15 TB programs, CDC,
and the National TB Controllers
Association (NTCA) convened 26
conference calls to consider variable
revisions based on surveillance
significance, ease of data collection, and
ability to yield meaningful and useful
data. The proposed revision further
benefited from review by TB experts
active in research and field services and
was pilot-tested in two phases.
Revisions resulting from stakeholder
input include the capture of data on
verified TB cases who do not meet the
national surveillance definition since
counted by another U.S. area, TB
treatment was initiated in another
country, or TB recurred less than 12
months after completion of therapy. The
year the case was reported and the
reporting jurisdiction were incorporated
into state case identification number
with fields for linking state case
numbers to allow better tracking of such
cases. New variables reflecting
diagnostic updates since 1993 include
nucleic acid amplification, interferon
gamma release assay, computerized
tomography, and genotyping. The dates
of tuberculin skin test and of specimen
collection for other diagnostic tests,
along with result dates by laboratory
type, were added. The primary reason
the patient was evaluated for TB
disease, and reasons for extending TB
therapy beyond one year were added.
Risk characteristics such as diabetes,
end-stage renal disease, post-organ
transplantation, other
immunosuppression, anti-tumor
necrosis factor-alpha therapy, contact
with a drug-resistant case, contact with
an infectious case, missed contacts,
incomplete treatment for latent TB
infection, immigration status for TB
screening, and parental origin and
international background for pediatric
cases will also be collected. A variable
was added to capture whether the TB
patient moved during treatment and if
so, where, with a check box to indicate

E:\FR\FM\01AUN1.SGM

01AUN1

Federal Register / Vol. 72, No. 147 / Wednesday, August 1, 2007 / Notices
transnational referral. Modifications
include updates to drug regimens and
drug susceptibility tests. Date of death
and whether TB was a cause of death
were added to status at diagnosis. Major
site and additional sites of TB disease
were combined to a single question.
Smear, pathology, or cytology now
capture histology results in addition to
microbiology, and a single field for
anatomic specimen code replaced two
codes for positive specimens. Initial
chest radiograph or other chest imaging
was updated to capture whether an
abnormal chest image shows a cavity or
miliary TB, replacing miliary as a site of
disease and simplifying check boxes for
radiograph as cavitary, consistent with
TB, stable, worsening, improving, or
unknown. Whether patients were under
custody of Immigration and Customs
Enforcement was added to the
correctional facility variable, and
occupation was modified to capture the
past year, with check boxes to
differentiate persons not eligible for
employment from the unemployed.
Type of health care provider was

clarified with categories of outpatient
care. Reasons for culture conversion not
being documented were incorporated,
and adverse treatment event and death
were added as reasons TB therapy
stopped or never started. Deletions
include removal of: (1) Soundex, a
software code; (2) a text field to indicate
who submitted the RVCT; (3) a check
box asking whether the case was
anergic; (4) CDC AIDS patient number;
(5) how HIV positive status was
determined; (6) a check box for more
than one additional site of TB disease;
and (7) site of directly observed therapy.
DTBE is currently working with
stakeholders and software team
members towards development and
implementation of an updated software
module for the transition from the
current software for RVCT data entry
and electronic transmission of reports to
CDC to collection and reporting of
revised RVCT data. Following the
transition, respondents will be able to
use either the CDC associated TB
module or their own TB surveillance
application to collect and report RVCT

42097

data to CDC. CDC publishes an annual
report using RVCT data to summarize
national TB statistics and also
periodically conducts special analyses
for publication to further describe and
interpret national TB data. These data
assist in public health planning,
evaluation, and resource allocation.
Reporting areas also review and analyze
their RVCT data to monitor local TB
trends, evaluate program success, and
focus resources to eliminate TB. No
other Federal agency collects this type
of national TB data. In addition to
providing technical assistance on the
use of RVCT, CDC provides technical
support for reporting software. In this
request, CDC is requesting approval for
approximately 8050 burden hours, an
estimated increase of 490 hours. This
increase is due to the addition of
information on new clinical diagnostic
tests and factors to identify high-risk
patients. There is no cost to respondents
other than their time to participate in
the survey.

ESTIMATE OF ANNUALIZED BURDEN HOURS
Types of respondents

Number of
respondents

No. of
responses per
respondent

Average burden per
response
(in hours)

Total burden
(in hours)

Local, state, and territorial health departments ...............................................

60

230

35/60

8050

Dated: July 26, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–14886 Filed 7–31–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–07–07BI]

jlentini on PROD1PC65 with NOTICES

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and

VerDate Aug<31>2005

20:12 Jul 31, 2007

Jkt 211001

send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Rapid HIV Testing in Community
Mental Health Settings Serving African
Americans—New—National Center for
HIV, Viral Hepatitis, STD and TB

PO 00000

Frm 00056

Fmt 4703

Sfmt 4703

Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
People with chronic mental illness,
including those with substance use
disorders, are at increased risk of HIV
infection compared with the general
population. However, not enough is
known about the risk behaviors,
willingness to be tested for HIV, and
HIV prevalence among persons with
chronic mental illness. In addition, the
interrelations among diagnosis of HIV
infection, compliance with medical
care, subsequent risk behaviors, and the
course of mental illness have not been
well-described. Mental health clinics
are an important setting for HIV rapid
testing and promoting prevention efforts
against the transmission of HIV
infection.
The objectives of this project are to (1)
increase the number of mental health
providers who routinely provide HIV
counseling, testing, and linkage to care
in settings that provide mental health
care, especially those serving African
American communities; and (2) describe
the relationship between mental illness,

E:\FR\FM\01AUN1.SGM

01AUN1